SLATTERY JOSEPH P 4
4 · Replimune Group, Inc. · Filed Apr 7, 2026
Research Summary
AI-generated summary of this filing
Replimune (REPL) Director Joseph Slattery Receives 44,500-Share Award
What Happened
Joseph P. Slattery, a director of Replimune Group, Inc. (REPL), was granted a derivative award on April 1, 2026 covering 44,500 shares. The filing reports the acquisition price as $0.00 (derivative award/option). The award vests in full on April 1, 2027. This was a compensation grant (not an open-market purchase or sale) and does not represent an immediate cash purchase or sale of stock.
Key Details
- Transaction date: 2026-04-01 (reporting period date); Form 4 filed 2026-04-07 (late filing).
- Transaction type/code: Award/Grant (A) — derivative (option-style award) for 44,500 shares, reported at $0.00.
- Vesting: Shares underlying the option vest entirely on April 1, 2027 (footnote).
- Shares owned after transaction: not disclosed in the Form 4 filing.
- Filing timeliness: Form 4 was filed late; filer cites an inadvertent administrative error (timeliness flag = L). Late filings delay public disclosure but do not change the substance of the grant.
Context
This is a typical director compensation award intended for retention; it is not the same as an insider purchasing shares on the open market. Because it's a derivative grant with a future vesting date, it does not necessarily indicate immediate buying or selling intent. Retail investors should view grants as routine compensation unless accompanied by other trading activity from the insider.
Insider Transaction Report
- Award
Stock Option (right to buy)
[F1]2026-04-01+44,500→ 44,500 totalExercise: $7.61Exp: 2036-04-01→ Common Stock (44,500 underlying)
Footnotes (1)
- [F1]The shares underlying this option vest entirely on April 1, 2027.